THE CURRENT STATE OF SPECIALTY PHARMACY:

CHALLENGES AND OPPORTUNITIES

Specialty pharmaceuticals continue to experience growth in the marketplace and are a significant part of the near and mid-term pipeline (25 novel drugs and 6 expanded indications are expected in 20171).

DMD has revisited this dynamic marketplace to help uncover the challenges and opportunities in the specialty pharmacy space.

IN THIS WHITEPAPER:

   Review of sustainability in the face of reimbursement                 pressures
   Impact of DIR Fees
   Taking full advantage of technology & data


Reference: 1. Diplomat. (2016). Specialty Drug Approvals: 2016 Highlights and 2017 Projections. Retrieved March 3, 2017 from https://diplomat.is/news-and-media/white-papers/speciality-drug-approvals-2016-highlights-2017-projections/.